Gara Jalqabaatti › Anemiyaa Refractory Kan Blasts Baay'ee Qabu
Qorannoo klinikaalii Anemiyaa Refractory Kan Blasts Baay'ee Qabu Ameerikaa Keessatti hirmaatuu
Qorannoo 19 Anemiyaa Refractory Kan Blasts Baay'ee Qabu f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Houston, TXQorannoo 6
- Seattle, WAQorannoo 5
- New York City, NYQorannoo 3
- Boston, MAQorannoo 3
- Washington, DCQorannoo 3
- Columbus, OHQorannoo 3
Naannoon
- MarylandQorannoo 3
- MassachusettsQorannoo 3
- New YorkQorannoo 3
- North CarolinaQorannoo 3
- OhioQorannoo 4
- TexasQorannoo 7
- WashingtonQorannoo 5
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 6 hanga 70 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT01861106Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 hanga 120 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06303193Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 4 hanga 80 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT01174108Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT00801489Luspatercept + Darbepoetin in MDS
Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07096297Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT03383575Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT07249346Personalized NK Cell Therapy in CBT
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 15 hanga 80 · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT02727803Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 60 · Saalaa hunda · Haaromfame 25-Wax-2026 · NCT03314974211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT03670966211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT03128034MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
Namoota walitti qabaa jira
Umuriin 0 hanga 25 · Saalaa hunda · Haaromfame 13-Cam-2026 · NCT05794880A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Elb-2026 · NCT04256317Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Namoota walitti qabaa jiraSadarkaa 1/2
1 Month – 25 Years · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT06839456MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 60 · Saalaa hunda · Haaromfame 06-Elb-2026 · NCT05735717A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 66 · Saalaa hunda · Haaromfame 17-Bit-2026 · NCT06859424Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 21 · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT04644016Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Mud-2025 · NCT06680752HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
Namoota walitti qabaa jiraSadarkaa 2
3 Months · Saalaa hunda · Haaromfame 12-Sad-2025 · NCT02143830Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.